Abstract The prevalence and magnitude of childhood and adult obesity and diabetes are increasing dramatically. FOXO 1a and FOXO 3a will be evaluated in this study, in an effort to identify genetic polymorphisms in potential candidate genes that may be associated with body mass index (BMI), and metabolic syndrome (MS). Also to assess whether there is a relation between insulin sensitivity, and genotype, we will test the relation between fasting insulin, glucose, insulin resistance, insulin secretion and genotype.
In this study we demonstrated that FOXO3a mutant is correlated with HOMA-IR (marker of insulin resistance), HOMA-B index (marker of insulin secretion) and total cholesterol while as regards FOXO1a there was only an association between LDL cholesterol and mutant type of FOXO1a.
Introduction
Metabolic syndrome is the clustering of heterogeneous metabolic abnormalities, mainly obesity, dyslipidemia insulin resistance, hyperglycemia and hypertension that may cause an increased risk of cardiovascular morbidity and mortality [1] .
Obesity is characterized by a body mass index (BMI) of over 30 kg/m 2 . The prevalence of obesity will rise to approximately 700 million people worldwide in 2015 [2] .
It is closely associated with a number of pathological disorders, such as non-insulin-dependent diabetes, hypertension, cancer, gallbladder disease and atherosclerosis [3] . Obesity is a multifactorial disease with genetic and environmental origins, resulting from an imbalance between energy intake and expenditure [4] . A large number of genetic association studies have suggested that polymorphic variants in genes that regulate energy metabolism, such as proliferator-activated receptor-c, b3-adrenergic receptor, leptin receptor, glucocorticoid receptor, and tumor necrosis factor, may predispose individuals to become obese [5] . Additionally, obesity induces insulin resistance, and a high fat diet is its major cause as well as insulin resistance. This suggests a close association between insulin signaling and obesity [6] .
FOXO proteins are involved in several pathways responsible for cell metabolism, onset of diabetes mellitus and diabetic complications; however other studies suggest that they are closely linked to the prevention of these complications through the preservation of cellular energy reserves and mitochondrial integrity [7] .
The family of Forkhead Box 0 (FOXO) transcription factors, in particular, FOXO1, FOXO 3a, and FOXO4, has been implicated to play a critical role in the control of proliferative and apoptotic processes. Initial work has linked metabolic insulin signaling and life-span extension with these transcription factors in multiple species [8] .
Genome-wide association study in the Framingham population suggested that eight SNPs (Single Nucleotide Polymorphisms) are strongly associated with the age of death. Among these eight, two SNPs, are located in the FOXO1A gene. In addition, FOXO1A and FOXO3A are critical downstream molecules of AKT1 and are inactivated by AKT1-mediated insulin signaling pathways that regulate the cell cycle, apoptosis, stress resistance and metabolism [9] .
FOXO 1a and FOXO 3a will be evaluated in this study, in an effort to identify genetic polymorphisms in potential candidate genes that may be associated with body mass index, and metabolic syndrome.
Also to assess whether there is a relation between insulin sensitivity, and genotype, we will test the relation between fasting insulin, glucose, insulin resistance, insulin secretion and genotype.
Materials and methods

Patients
A total number of 248 presenting normal, over weight and obese individuals were recruited from NRC pediatrics and internal medicine clinics, Abou El-Rish Hospital, Cairo University and Ain Shams Hospital which included 100 children and 148 adults.
They were divided by body mass index (BMI) as follows, normal and over weight (obese are included within this group).
The exclusion criteria were: (1) the presence of type II diabetes or of first-grade relatives with type II diabetes, (2) hypothyroidism, (3) the presence of coronary artery disease (CAD), chronic kidney and liver diseases, also collagen diseases, (4) patients on corticosteroid medication and (5) obesity as a part of syndrome. In all subjects, a complete medical history was obtained using questionnaire. History taking included questions about smoking habits, history of hypertension and type II diabetes and current medication used. Diagnosis of type II diabetes was based on the history of hypoglycemic treatment and/or confirmed fasting blood glucose >126 mg/ dl (7.0 mmol/L). The metabolic syndrome was diagnosed in children and adults according to International Diabetes Federation (IDF) criteria [10] (Table I) .
Diagnosis of hypertension was based on the presence of elevated systolic (>140 mmHg) and/or diastolic (>90 mmHg) blood pressure, and/or the current use of antihypertensive medications.
Body weight and height were measured, body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared.
Laboratory measurements
Blood samples after 12 h fasting were collected from all individuals by a sterile venipuncture and are divided as follows: two milliliters of blood in a sterile EDTA containing vacutainer for DNA extraction using DNA extraction kits (QIAGEN); three milliliters of blood in a plain vacutainer and allowed to clot for 30 min before centrifugation for 10 min. Then the sera separated from the clotted samples are used for lipid profile (total cholesterol, HDL, LDL, VLDL and triglycerides) and fasting glucose. All were measured by an Olympus AU 400 auto analyzer. Insulin was measured by the chemiluminescence technique (on Immulite auto analyzer). Insulin resistance was calculated by the homeostatic model assessment-insulin resistance (HOMA-IR) using the following formula [9] : HOMA-IR = fasting insulin (mU/L) X plasma glucose (mmol/L)/ 22.5. Insulin secretion (b-cell function) was calculated by the homeostatic model assessment-b-cell function (HOMA-b) using the following formula [9] : HOMA-b = 20 · fasting insulin level (lIU mol)/fasting glucose À3.5.
Genotype analysis of foxo gene
Two milliliters of blood in a sterile EDTA containing vacutainer was obtained from each subject and stored at À80°C until DNA extraction. Genomic DNA was isolated from blood of overweight, obese individuals and controls, followed by RT-PCR Assay.
Extraction of DNA
Extraction of DNA was done from whole blood (collected in vacutainer EDTA tubes). The QIAamp Blood Kit was used for DNA extraction (Cat. No. 51106; Qiagen Inc., Valencia, CA, http://www.qiagen.com).
a. The samples were equilibrated to room temperature. b. Heat block was heated to 56°C. c. Buffer AW1, Buffer AW2, and QIAGEN protease ensured that they had been prepared according to the instructions. d. All centrifugation steps were carried out at room temperature. e. 200 ll of the whole blood yielded 3-12 lg of DNA.
Procedure
1. 200 ll whole blood was added to 20 ll QIAGEN protease, and 200 ll Buffer AL into a 1.5 ml low binding microcentrifuge tube and mixed by vortexing. 2. Incubated at 56°C for 10 min. 3. Spinned down briefly to remove drops from the inside of the tube. 4. 200 ll of 96-100% ethanol was added and mixed by vortexing. 5. The mixture was carefully applied from the step above to a QIAamp spin column, centrifuged for 1 min in the QIAamp spin column and was carefully opened and operated at full speed (15,000 g). The tube containing the filtrate was discarded. 6. The DNA would be bound to the filters in the spin columns. Column was placed in a clean 2 ml collection tube. 7. QIAamp spin column was opened and 500 ll Buffer AW1 was added without hitting the rim. The cap was closed and centrifuged for 1 min at full speed. QIAamp spin column was placed in a clean 2 ml collection tube. 8. The QIAamp spin column was carefully opened and was added 500 ll Buffer AW2. The cap was closed and centrifuged in the QIAamp column for 3 min at maximum speed. 9. The 2 ml collection tube containing the filtrate was discarded, the QIAamp spin column was placed in a new collection tube and spun for 1 min to remove residual buffer AW2. 10. The spin column was placed in a clean 1.5 ml low binding microcentrifuge tube. Two hundred microliters Buffer AE or distilled water was added to the spin column, incubated at room temperature for 5 min to elute the DNA and centrifuged 1 min at full speed. One microliter of extracted DNA was used for a 50 ll PCR. 11. Stored at 4°C.
RT-PCR assay
Using light cycler system to detect FOXO 1a and FOXO 3a gene mutation (Roche Diagnostics, Mannheim, Germany) according to manufacturer's instructions, PCR amplification was performed using FOXO 1a and FOXO 3a primer pairs: After amplification, point mutations were detected by a melting-curve analysis. The result of the melting curve analysis yielded three characteristic curves: a curve with a single early peak (homozygous wild type), a curve with a single late peak (homozygous mutant) and a curve with two peaks (heterozygous genotype).
Statistical analysis
The standard computer program SPSS for Windows, release 12.0 (SPSS Inc., USA) was used for data entry and analysis. All numeric variables were expressed as mean ± standard error of mean (SE). Comparison of different variables in various groups was done using Student's t test and Mann-Whitney test for normal and nonparametric variables, respectively. Pearson's and Spearman's correlation tests (r = correlation coefficient) were used for correlating normal and non-parametric variables, respectively. Mean values between different groups were compared using one way ANOVA test. A probability (p) less than 0.05 (<0.05) is considered significant. Table 1 shows comparison between normal and obese individuals as regards systolic blood pressure, diastolic blood pressure, HOMA IR, HOMA B Index, T-cholesterol, triglycerides, HDL-C and LDL-C in children and adults. There is a significant increase in insulin secretion among obese children represented by HOMA B Index (P = 0.26), while in adults there is a significant increase in systolic blood pressure (P = 0.00), diastolic blood pressure (P = 0.001), HOMA IR (P = 0.002), T-cholesterol (P = 0.012), triglycerides (P = 0.001) and LDL-C (P = 0.003) among obese individuals when compared by normal weight ones. Table 2 shows comparison regarding the presence of metabolic syndrome (MS) in children and adults. A highly significant correlation is present in children diagnosed with MS as regards just triglycerides (P = 0.001), while in adults there is a strong significant correlation in those diagnosed with MS as regards systolic blood pressure (P = 0.000), diastolic blood pressure (P = 0.012), T-cholesterol (P = 0.005), triglycerides (P = 0.00) and LDL-C (P = 0.015). Correlation between adults diagnosed with MS as regards HOMA IR is also significant (P = 0.047).
Results
Spearman correlation in the studied children group revealed a significant correlation between the HOMA IR and each of the following; BMI (r = 0.437; P = 0.037), HOMA B Index (r = 0.715; P = 0.000), T-cholesterol (r = 0.525; P = 0.006), triglycerides (r = 0.421; P = 0.032) and LDL-C (r = 0.456; P = 0.019). Also a significant correlation was found between BMI and triglycerides (r = 0.428; P = 0.042), T-cholesterol and HDL-C (r = 0.391; P = 0.048) ( Table 3) .
Pearson correlation in the studied adult group showed a significant correlation between the HOMA IR and each of the following; HOMA B Index (r = 0.734; P = 0.000), T-cholesterol (r = 0.290; P = 0.008), and LDL-C (r = 0.272; P = 0.014). Also a significant correlation was found between T-cholesterol and triglycerides, HDL-C and LDL-C (r = 0.450; P = 0.000, r = 0.346; P = 0.000; r = 0.942; P = 0.000, respectively), as well as a correlation was found between diastolic blood pressure, T-cholesterol and LDL-C (r = 0.371; P = 0.003; r = 0.334; P = 0.14, respectively) ( Table 4 ). The overall number of individuals that underwent genotyping for Foxo1a was 95 (24 children and 71 adults), all studied children had no mutation in foxo 1a while 9.85% of adults revealed homozygous mutation and just only 2.81% of the studied adults showed heterozygous mutation (Table 5) . One hundred and seven subjects underwent Foxo3a genotyping (23 children and 84 adult), homozygous and heterozygous mutation in foxo3a in children were the same (8.69%), while 8.33% of adults were homozygous mutants for foxo3a gene and 2.38% were heterozygous mutants (Table 5 ).
An association was found among the studied group (children and adults) as regards foxo3a gene polymorphism and HOMA IR, HOMA B Index and T-cholesterol (P = 0.022, 0.011 and 0.028, respectively), while there was only an association between LDL-C and foxo1a gene polymorphism among the studied group of children and adults (P = 0.023) ( Table 6 ).
Discussion
Pancreatic b cells are located in the islets of Langerhans which constitute the endocrine compartment of the pancreas. B-cells produce insulin and secrete it in response to elevations in circulating blood glucose and to other signaling molecules, providing a key contribution to glucose homeostasis and to the coordination of metabolism within the body. FOXO factors are expressed in b cells, and many pathways that have been shown to regulate FOXO function in other tissues are active in b cells [8] .
FOXO1 is the most predominantly expressed FOXO factor in isolated mice islets as well as in the b TC-3 b cell line. In mice islets, FOXO3 is expressed at a lower level; while FOXO4 is apparently undetectable [11] . FOXO1 has also been shown to be expressed in isolated human islets [12] . Interestingly, foxo1mRNA levels are more elevated in islets of diabetic when compared with non-diabetic patients, but the reason for this is unknown [8] . FOXO proteins are involved in several pathways responsible for cell metabolism, onset of diabetes mellitus and diabetic complications [9] . The range of applicable disease processes that can be affected by aberrant FOXO protein function appears to be limitless and might arise from the observation that FOXO proteins can both enhance as well as repress gene function in processes that involve cell apoptosis, cell cycle regulation and cell senescence. As a result, it must be recognized that simplistic recipes to modulate FOXO proteins can become a double-edge sword to yield both beneficial and detrimental biological outcomes [9] .
In this study we demonstrated that FOXO3a mutant is correlated with HOMA-IR, HOMA-B index (marker of insulin secretion) and total cholesterol while as regards FOXO1a there .958 .000
.233 .253 was only an association between LDL cholesterol and mutant type of FOXO1a. Clinical studies suggest that FOXO proteins play a significant role in diabetes mellitus, oxidative stress, immune system function and cancer. In a study of 734 individuals, polymorphism of FOXO3a displayed a significant association with body mass index such that the highest body mass index was present in individuals homozygous for this allele [13] . Analysis of the genetic variance in FOXO1a and FOXO3a on metabolic profiles, age-related diseases, fertility, fecundity and mortality have observed higher HbA1c levels and increased mortality risk associated with specific haplotypes of FOXO1a. In addition, there was an increased risk of stroke in two haplotypes of FOXO3a, which suggests an association with cerebral oxidative stress disorders such as diabetes and stroke with FOXO1a and FOXO3a [14] .
Two metabolic problems were recognized in our obese patients when compared to their corresponding healthy controls. These are dyslipidemia and insulin resistance although these problems were obvious in obese adults than obese children. Dyslipidemia was manifested in the form of elevated cholesterol, triglycerides and LDL levels in the obese adult patients compared to controls. Our results are in agreement with Ö nal and colleagues who reported dyslipidemia of higher triglyceride and lower HDL levels in insulin resistant subjects [15] . This may increase their risk of developing cardiovascular diseases in the presence of high systolic and diastolic blood pressure [16] .
Insulin resistance was an evident finding in our obese adults compared to controls, also a higher fasting insulin level than normal, although fasting and post prandial blood glucose were not significantly different between the two groups. This may be due to the release of a high amount of non-esterified fatty acids, glycerol hormones and proinflammatory cytokines from adipose tissue [17] . In children there was a significant correlation between obese and normal as regards insulin secretion represented by HOMA-B Index.
In adults resistance to insulin leads finally to type 2 diabetes taking into consideration that it has a direct link to changes in lipid profile in obese patients as proved by Schaefer and his team [18] . Moreover, the development of type 2 diabetes mellitus is induced by the decreased insulin sensitivity, which leads to increased insulin production. This imbalance causes a predisposition to several metabolic disorders such as early atherosclerosis, progressive obesity, acanthosis nigricans, increase in 
Conclusion
There is an association between FOXO gene mutation, insulin resistance and secretion and this imbalance is associated with metabolic syndrome, which includes obesity, insulin resistance, hyperlipidemia, and hypertension. Our findings suggest the utility of the HOMA indexes for assessing insulin resistance and b-cell function in identifying individuals who are at high risk and who may benefit from interventions for diabetes and cardiovascular disease prevention. 
